Accrete Pharmaceuticals manufactures and supplies Cabozantinib Intermediates for pharmaceutical and bulk drug manufacturing requirements. Our product portfolio includes 1-((4-Fluorophenyl)carbamoyl)cyclopropane carboxylic acid (CAS No. 849217-48-7) and 4-Chloro-6,7-Dimethoxyquinoline (CAS No. 35654-56-9). These chemical intermediates form part of our pharmaceutical product range for domestic and international markets.
Established in 2005, Accrete Pharmaceuticals Private Limited was founded by committed professionals with an initial focus on anti-cancer products. The company operates a cGMP pharmaceutical intermediate manufacturing facility near Hyderabad, Telangana, India, supporting its pharmaceutical manufacturing and product supply activities.
Our manufacturing approach focuses on product quality, established manufacturing methodologies, proper documentation and customer satisfaction. We follow applicable quality procedures and scientifically derived technologies to support pharmaceutical intermediate manufacturing requirements.
Manufacturing activities are supported by a clean manufacturing environment, equipment validation, process validation, standard operating procedures (SOPs), and relevant quality records. Accrete Pharmaceuticals serves pharmaceutical industry requirements across India and international markets.
Request Product Information1-((4-Fluorophenyl)carbamoyl)cyclopropane carboxylic acid
Accrete Pharmaceuticals manufactures and supplies Cabozantinib intermediates for pharmaceutical manufacturing and related chemical synthesis requirements. Our product portfolio includes 1-((4-Fluoro phenyl) Carbamoyl) Cyclopropane Carboxylic acid (CAS No. 849217-48-7) and 4-Chloro-6,7-Dimethoxy Quinoline (CAS No. 35654-56-9). These products are part of our pharmaceutical intermediate portfolio. Contact our team for product details and supply enquiries.
Accrete Pharmaceuticals manufactures and supplies 1-((4-Fluoro phenyl) Carbamoyl) Cyclopropane Carboxylic acid (CAS No. 849217-48-7). This compound is listed in our Cabozantinib intermediate product range. Contact us for product specifications, availability and supply-related enquiries.
Enquire About This ProductAccrete Pharmaceuticals manufactures and supplies 4-Chloro-6,7-Dimethoxy Quinoline (CAS No. 35654-56-9). This compound is included in our Cabozantinib intermediate product range. Get in touch with our team for product information, availability and supply enquiries.
Enquire About This ProductAccrete Pharmaceuticals follows quality-focused manufacturing practices for its pharmaceutical intermediate portfolio. Our cGMP manufacturing facility near Hyderabad, Telangana, supports organized production processes and customer-specific requirements.
We emphasize quality methodologies, scientifically derived technologies, equipment validation, and process validation to support manufacturing operations. Proper SOPs and records are maintained as part of our quality-oriented approach.
Our team focuses on supplying products with relevant documentation while addressing customer requirements for domestic and international markets.
Discuss Your RequirementsWe follow established quality methodologies throughout our manufacturing processes.
Our facility near Hyderabad supports pharmaceutical intermediate manufacturing under cGMP-oriented practices.
We emphasize proper documentation and maintained manufacturing records.
We work with customers to understand their product specifications and supply requirements.
Contact Accrete Pharmaceuticals for product information, specifications, and supply enquiries regarding Cabozantinib Intermediates.
Available Products:
Discuss Your Product Requirements
Share your requirements with our team for product information and enquiry support.